1. Tsai I-T, Wang C-P, Lu Y-C, Hung W-C, Wu C-C, Lu L-F, et al. The burden of major adverse cardiac events in patients with coronary artery disease. BMC cardiovascular disorders. 2017; 17(1):1.
2. Loffi M, Piccolo R, Regazzoni V, Di Tano G, Moschini L, Robba D, et al. Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection. Open heart. 2020; 7(2):e001428.
3. Timmis A, Townsend N, Gale CP, Torbica A, Lettino M, Petersen SE, et al. European Society of Cardiology: cardiovascular disease statistics 2019. European heart journal. 2020; 41(1):12-85.
4. Ralapanawa U, Sivakanesan R. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. Journal of epidemiology and global health. 2021; 11(2):169-77.
5. Álvarez-Álvarez MM, Zanetti D, Carreras-Torres R, Moral P, Athanasiadis G. A survey of sub-Saharan gene flow into the Mediterranean at risk loci for coronary artery disease. European Journal of Human Genetics. 2017; 25(4):472-6.
6. Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics. Journal of cellular physiology. 2019; 234(10):16812-23.
7. Kim EK, Hahn J-Y, Park TK, Lee JM, Song YB, Chang S-A, et al. Prognostic implications of diastolic dysfunction change in patients with coronary artery disease undergoing percutaneous coronary intervention. Circulation Journal. 2019; 83(9):1891-900.
8. Cho D-H, Kim M-A, Choi J, Kim M-N, Park S-M, Kim H-L, et al. Sex differences in the relationship between left ventricular diastolic dysfunction and coronary artery disease: from the korean women's chest pain registry. Journal of Women's Health. 2018; 27(7):912-9.
9. AlJaroudi WA, Thomas JD, Rodriguez LL, Jaber WA. Prognostic value of diastolic dysfunction: state of the art review. Cardiology in review. 2014; 22(2):79-90.
10. Mansour MJ, Chammas E, Hamoui O, Honeine W, AlJaroudi W. Association between left ventricular diastolic dysfunction and subclinical coronary artery calcification. Echocardiography. 2020; 37(2):253-9.
11. AlJaroudi W, Alraies MC, Halley C, Rodriguez L, Grimm RA, Thomas JD, et al. Impact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction. Circulation. 2012; 125(6):782-8.
12. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Journal of Echocardiography. 2016; 17(12):1321-60.
13. Liu S, Moussa M, Wassef AW, Hiebert BM, Hussain F, Jassal DS. The utility of systolic and diastolic echocardiographic parameters for predicting coronary artery disease burden as defined by the SYNTAX score. Echocardiography. 2016; 33(1):14-22.
14. Bouthoorn S, Valstar GB, Gohar A, den Ruijter HM, Reitsma HB, Hoes AW, et al. The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis. Diabetes and Vascular Disease Research. 2018; 15(6):477-93.
15. Abalı G, Akpınar O, Nisanoğlu V, Ilgenli TF. Severity of coronary artery disease and echocardiographic parameters of ventricular diastolic function. Echocardiography. 2014; 31(7):809-13.
16. Mukhopadhyay T, Gupta A, Biswas U, Majumdar B. Severity of coronary artery disease and echocardiographic parameters of ventricular diastolic function in patients with non-ST-elevation acute coronary syndrome. Int J Med Sci Public Health. 2019; 8(1):86-90.